Skip to content

Melanotan II studies: 324 papers with results

Page 5 of 7

  1. Gqα/G11α deficiency in dorsomedial hypothalamus leads to obesity resulting from decreased energy expenditure and impaired sympathetic nerve activity.

    Wilson EA · American journal of physiology. Endocrinology and metabolism · 2021

    Animal study (in vivo) · mouse · 2 results

  2. Modulatory function of NMDA glutamate receptor on MC3/MC4 receptors agonist-induced hypophagia in neonatal meat-type chicken.

    Ahmadi F · Veterinary research communications · 2017

    Animal study (in vivo) · chicken · 3 results

  3. Inconsistencies in the hypophagic action of intracerebroventricular insulin in mice.

    Mc Allister E · Physiology & behavior · 2015

    Animal study (in vivo) · mouse · 1 result

  4. Profound and rapid reduction in body temperature induced by the melanocortin receptor agonists.

    Xu Y · Biochemical and biophysical research communications · 2014

    Animal study (in vivo) · 6 results

  5. Effects of ghrelin, corticotrophin-releasing hormone, and melanotan-II on food intake in rats with paraventricular nucleus lesions.

    Wang J · Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association · 2007

    Animal study (in vivo) · rat · 2 results

  6. Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats.

    van Dijk G · Endocrinology · 2005

    Animal study (in vivo) · rat · 5 results

  7. Preformulation studies with melanotan-II: a potential skin cancer chemopreventive peptide.

    Lan EL · Journal of pharmaceutical sciences · 1994

    Animal study (in vivo) · rat · 3 results

  8. Hindbrain melanocortin 3/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide.

    Fortin SM · Physiology & behavior · 2020

    Animal study (in vivo) · 4 results

  9. Control of appetite, blood glucose, and blood pressure during melanocortin-4 receptor activation in normoglycemic and diabetic NPY-deficient mice.

    da Silva AA · American journal of physiology. Regulatory, integrative and comparative physiology · 2018

    Animal study (in vivo) · mouse · 8 results

  10. The nutritional induction of COUP-TFII gene expression in ventromedial hypothalamic neurons is mediated by the melanocortin pathway.

    Sabra-Makke L · PloS one · 2010

    Animal study (in vivo) · mouse · 4 results

  11. Intermittent MTII application evokes repeated anorexia and robust fat and weight loss.

    Zhang Y · Peptides · 2010

    Animal study (in vivo) · rat · 8 results

  12. Melanocortin receptor agonist melanotan-II microinjected in the nucleus accumbens decreases appetitive and consumptive responding for food.

    Eliason NL · Neuropeptides · 2022

    Animal study (in vivo) · mouse · 5 results

  13. Defense of Elevated Body Weight Setpoint in Diet-Induced Obese Rats on Low Energy Diet Is Mediated by Loss of Melanocortin Sensitivity in the Paraventricular Hypothalamic Nucleus.

    Luchtman DW · PloS one · 2015

    Animal study (in vivo) · rat · 2 results

  14. The use of telemetry technology to test the proerectile effect of melanotan-II (MT-II) in conscious rats.

    Giuliano F · European urology · 2005

    Animal study (in vivo) · rat · 2 results

  15. The effects of the melanocortin agonist (MT-II) on subcutaneous and visceral adipose tissue in rodents.

    Strader AD · The Journal of pharmacology and experimental therapeutics · 2007

    Animal study (in vivo) · mouse and rat · 7 results

  16. Evaluation of the role of melanocortin 3 and 4 receptors in leptin-stimulated and spontaneous growth hormone secretion in rats.

    Watanobe H · Neuroendocrinology · 2003

    Animal study (in vivo) · rat · 1 result

  17. Evidence for a feeding related association between melanocortin in the NTS and Neuropeptide-Y in the PVN.

    Kim EM · Appetite · 2023

    Animal study (in vivo) · rat · 2 results

  18. Anatomical dissociation of melanocortin receptor agonist effects on taste- and gut-sensitive feeding processes.

    Baird JP · American journal of physiology. Regulatory, integrative and comparative physiology · 2011

    Animal study (in vivo) · 8 results

  19. Melanocortin agonism in a social context selectively activates nucleus accumbens in an oxytocin-dependent manner.

    Ford CL · Neuropharmacology · 2024

    Animal study (in vivo) · prairie vole · 2 results

  20. Zebrafish Bioassay for Screening Therapeutic Candidates Based on Melanotrophic Activity.

    Hong TI · International journal of molecular sciences · 2021

    Animal study (in vivo) · zebrafish · 1 result

  21. CAPS2 deficiency induces proopiomelanocortin accumulation in pituitary and affects food intake behavior in mice.

    Fujima S · Neuroscience letters · 2020

    Animal study (in vivo) · mouse · 2 results

  22. Topical MTII Therapy Suppresses Melanoma Through PTEN Upregulation and Cyclooxygenase II Inhibition.

    Wu JC · International journal of molecular sciences · 2020

    Animal study (in vivo) · mouse · 14 results

  23. Activation of the central melanocortin system chronically reduces body mass without the necessity of long-term caloric restriction.

    Côté I · Canadian journal of physiology and pharmacology · 2017

    Animal study (in vivo) · rat · 4 results

  24. Genetic and pharmacological mouse models of chronic melanocortin activation show enhanced baroreflex control of heart rate.

    Rinne P · Regulatory peptides · 2013

    Animal study (in vivo) · mouse · 3 results

  25. Antidepressant-like and antistress effects of the ACTH(4-10) synthetic analogs Semax and Melanotan II on male rats in a model of chronic unpredictable stress.

    Inozemtseva LS · European journal of pharmacology · 2024

    Animal study (in vivo) · rat · 10 results

  26. Inhibitory Effect of the Melanocortin Receptor Agonist Melanotan-II (MTII) on Feeding Depends on Dietary Fat Content and not Obesity in Rats on Free-Choice Diets.

    van den Heuvel JK · Frontiers in behavioral neuroscience · 2015

    Animal study (in vivo) · rat · 2 results

  27. Treatment with a melanocortin agonist improves abnormal lipid metabolism in streptozotocin-induced diabetic mice.

    Leckstrom A · Neuropeptides · 2011

    Animal study (in vivo) · mouse · 12 results

  28. Therapeutic Strategies Against Metabolic Imbalance in a Male Mouse Model With 5-HT2CR Loss-of-Function.

    Liu H · Endocrinology · 2024

    Animal study (in vivo) · mouse · 2 results

  29. Melanotan-II reverses memory impairment induced by a short-term HF diet.

    Wekwejt P · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2023

    Animal study (in vivo) · zebrafish · 3 results

  30. Melanotan II, a melanocortin agonist, partially rescues the impaired thermogenic capacity of pituitary adenylate cyclase-activating polypeptide deficient mice.

    McMillan TR · Experimental physiology · 2021

    Animal study (in vivo) · mouse · 2 results

  31. Activation of the central melanocortin system in rats persistently reduces body and fat mass independently of caloric reduction.

    Côté I · Canadian journal of physiology and pharmacology · 2018

    Animal study (in vivo) · rat · 3 results

  32. [Energy homeostasis regulated by an adipocyte-derived hormone--mechanism of leptin resistance and role of hypothalamic melanocortin signaling].

    Masuzaki H · Nihon rinsho. Japanese journal of clinical medicine · 2009

    Animal study (in vivo) · mouse · 4 results

  33. Accelerating sensory recovery after sciatic nerve crush: non-selective versus melanocortin MC4 receptor-selective peptides.

    Nijenhuis WA · European journal of pharmacology · 2004

    Animal study (in vivo) · rat · 1 result

  34. Co-treatment with melanotan-II, a potent melanocortin, does not protect against cisplatin ototoxicity.

    Wolters FL · Hearing research · 2002

    Animal study (in vivo) · guinea pig · 2 results

  35. Multiple metabolic signals in the CeA regulate feeding: The role of AMPK.

    Castro G · Molecular and cellular endocrinology · 2024

    Animal study (in vivo) · rat · 3 results

  36. [STUDYING THE ROLE OF BRAIN MELANOCORTIN RECEPTORS IN THE SUPPRESSING OF FOOD INTAKE UNDER ETHER STRESS IN MICE].

    Bazhan NM · Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova · 2015

    Animal study (in vivo) · mouse · 2 results

  37. Presynaptic melanocortin-4 receptors on vagal afferent fibers modulate the excitability of rat nucleus tractus solitarius neurons.

    Wan S · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008

    Ex vivo tissue · rat · 5 results

  38. CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputs.

    Hisadome K · Diabetes · 2011

    Ex vivo tissue · mouse · 1 result

  39. Agouti-related peptide and MC3/4 receptor agonists both inhibit excitatory hypothalamic ventromedial nucleus neurons.

    Fu LY · The Journal of neuroscience : the official journal of the Society for Neuroscience · 2008

    Ex vivo tissue · mouse · 5 results

  40. Neuropeptides, including neuropeptide Y and melanocortins, mediate lipolysis in murine adipocytes.

    Bradley RL · Obesity research · 2005

    Ex vivo tissue · mouse · 2 results

  41. Alpha-melanocyte-stimulating hormone suppresses antigen-induced lymphocyte proliferation in humans independently of melanocortin 1 receptor gene status.

    Cooper A · Journal of immunology (Baltimore, Md. : 1950) · 2005

    Ex vivo tissue · 1 result

  42. Characterization of the sea bass melanocortin 5 receptor: a putative role in hepatic lipid metabolism.

    Sánchez E · The Journal of experimental biology · 2009

    Ex vivo tissue · sea bass · 1 result

  43. AgRP-Expressing Adrenal Chromaffin Cells Are Involved in the Sympathetic Response to Fasting.

    Gupta R · Endocrinology · 2017

    Ex vivo tissue · mouse · 2 results

  44. Activation of the melanocortin-4 receptor causes enhanced excitation in presympathetic paraventricular neurons in obese Zucker rats.

    Ye ZY · Regulatory peptides · 2011

    Ex vivo tissue · rat · 6 results

  45. Regulation of neuropeptide Y release from hypothalamic slices by melanocortin-4 agonists and leptin.

    King PJ · Peptides · 2000

    Ex vivo tissue · rat · 2 results

  46. Food deprivation decreases responsiveness of ventromedial hypothalamic neurons to melanocortins.

    Li YZ · Journal of neuroscience research · 2004

    Ex vivo tissue · rat · 3 results

  47. Melanocortin regulation of histaminergic neurons via perifornical lateral hypothalamic melanocortin 4 receptors.

    Michael NJ · Molecular metabolism · 2020

    Ex vivo tissue · mouse · 4 results

  48. The role of the melanocortin 3 receptor in mediating the effects of gamma-MSH peptides on the adrenal.

    Harmer SC · Endocrine research · 2004

    Ex vivo tissue · rat · 1 result

  49. Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor.

    Haskell-Luevano C · Regulatory peptides · 2001

    In vitro (cells) · 1 result

  50. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist.

    Xiang Z · Biochemistry · 2006

    In vitro (cells) · 1 result

How PepBank reports evidence